Sitting systolic blood pressure

1. Dapagliflozin decreases sitting systolic blood pressure in humans (-8.8 mmHg (95% CI -13.2 to -4.4)).

   Human trialATTR-CM; intervention versus baseline10 mg once daily12 weeksn = 7

   Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study

   PloS one·7 Oct 2026

More on Dapagliflozin